nodes	percent_of_prediction	percent_of_DWPC	metapath
Decitabine—Nucleic Acid Synthesis Inhibitors—Cytarabine—lymphatic system cancer	0.352	1	CiPCiCtD
Decitabine—Cytarabine—lymphatic system cancer	0.258	1	CrCtD
Decitabine—DCK—Fludarabine—lymphatic system cancer	0.0956	0.594	CbGbCtD
Decitabine—DCK—Cytarabine—lymphatic system cancer	0.0653	0.406	CbGbCtD
Decitabine—Gemcitabine—Cytarabine—lymphatic system cancer	0.0244	0.124	CrCrCtD
Decitabine—Lamivudine—Cytarabine—lymphatic system cancer	0.0244	0.124	CrCrCtD
Decitabine—Zalcitabine—Cytarabine—lymphatic system cancer	0.0211	0.107	CrCrCtD
Decitabine—Clofarabine—Fludarabine—lymphatic system cancer	0.0128	0.065	CrCrCtD
Decitabine—Clofarabine—Cytarabine—lymphatic system cancer	0.0121	0.0614	CrCrCtD
Decitabine—Nelarabine—Fludarabine—lymphatic system cancer	0.0113	0.0575	CrCrCtD
Decitabine—Cytarabine—Fludarabine—lymphatic system cancer	0.0107	0.0544	CrCrCtD
Decitabine—Nelarabine—Cytarabine—lymphatic system cancer	0.0107	0.0543	CrCrCtD
Decitabine—Vidarabine—Fludarabine—lymphatic system cancer	0.0102	0.0517	CrCrCtD
Decitabine—Adenosine—Fludarabine—lymphatic system cancer	0.0102	0.0517	CrCrCtD
Decitabine—Cladribine—Fludarabine—lymphatic system cancer	0.0102	0.0517	CrCrCtD
Decitabine—Azacitidine—Fludarabine—lymphatic system cancer	0.0102	0.0517	CrCrCtD
Decitabine—Azacitidine—Cytarabine—lymphatic system cancer	0.00962	0.0488	CrCrCtD
Decitabine—Adenosine—Cytarabine—lymphatic system cancer	0.00962	0.0488	CrCrCtD
Decitabine—Vidarabine—Cytarabine—lymphatic system cancer	0.00962	0.0488	CrCrCtD
Decitabine—DNMT3A—Epigenetic regulation of gene expression—RRP8—lymphatic system cancer	0.000773	0.368	CbGpPWpGaD
Decitabine—DNMT1—Negative epigenetic regulation of rRNA expression—RRP8—lymphatic system cancer	0.000589	0.28	CbGpPWpGaD
Decitabine—DNMT1—Vinblastine—Vincristine—lymphatic system cancer	0.000584	1	CbGdCrCtD
Decitabine—DNMT1—Epigenetic regulation of gene expression—RRP8—lymphatic system cancer	0.000522	0.249	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—RRP8—lymphatic system cancer	0.000129	0.0615	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—RRP8—lymphatic system cancer	8.72e-05	0.0415	CbGpPWpGaD
Decitabine—Haemoglobin—Mitoxantrone—lymphatic system cancer	4.7e-05	0.0016	CcSEcCtD
Decitabine—Hypersensitivity—Teniposide—lymphatic system cancer	4.68e-05	0.00159	CcSEcCtD
Decitabine—Haemorrhage—Mitoxantrone—lymphatic system cancer	4.67e-05	0.00159	CcSEcCtD
Decitabine—Ill-defined disorder—Bleomycin—lymphatic system cancer	4.65e-05	0.00158	CcSEcCtD
Decitabine—Pharyngitis—Mitoxantrone—lymphatic system cancer	4.64e-05	0.00158	CcSEcCtD
Decitabine—Pulmonary embolism—Methotrexate—lymphatic system cancer	4.64e-05	0.00158	CcSEcCtD
Decitabine—Anaemia—Bleomycin—lymphatic system cancer	4.63e-05	0.00158	CcSEcCtD
Decitabine—Feeling abnormal—Fludarabine—lymphatic system cancer	4.6e-05	0.00157	CcSEcCtD
Decitabine—Asthenia—Teniposide—lymphatic system cancer	4.55e-05	0.00155	CcSEcCtD
Decitabine—Malaise—Bleomycin—lymphatic system cancer	4.52e-05	0.00154	CcSEcCtD
Decitabine—Pruritus—Teniposide—lymphatic system cancer	4.49e-05	0.00153	CcSEcCtD
Decitabine—Leukopenia—Bleomycin—lymphatic system cancer	4.49e-05	0.00153	CcSEcCtD
Decitabine—Cardiac disorder—Vincristine—lymphatic system cancer	4.45e-05	0.00152	CcSEcCtD
Decitabine—Alopecia—Carmustine—lymphatic system cancer	4.44e-05	0.00151	CcSEcCtD
Decitabine—Body temperature increased—Fludarabine—lymphatic system cancer	4.41e-05	0.0015	CcSEcCtD
Decitabine—Mental disorder—Carmustine—lymphatic system cancer	4.4e-05	0.0015	CcSEcCtD
Decitabine—Malnutrition—Carmustine—lymphatic system cancer	4.37e-05	0.00149	CcSEcCtD
Decitabine—Erythema—Carmustine—lymphatic system cancer	4.37e-05	0.00149	CcSEcCtD
Decitabine—Cough—Bleomycin—lymphatic system cancer	4.37e-05	0.00149	CcSEcCtD
Decitabine—Angiopathy—Vincristine—lymphatic system cancer	4.35e-05	0.00148	CcSEcCtD
Decitabine—Diarrhoea—Teniposide—lymphatic system cancer	4.34e-05	0.00148	CcSEcCtD
Decitabine—Mediastinal disorder—Vincristine—lymphatic system cancer	4.32e-05	0.00147	CcSEcCtD
Decitabine—Chest pain—Bleomycin—lymphatic system cancer	4.27e-05	0.00145	CcSEcCtD
Decitabine—Myalgia—Bleomycin—lymphatic system cancer	4.27e-05	0.00145	CcSEcCtD
Decitabine—Alopecia—Vincristine—lymphatic system cancer	4.24e-05	0.00144	CcSEcCtD
Decitabine—Back pain—Carmustine—lymphatic system cancer	4.23e-05	0.00144	CcSEcCtD
Decitabine—Discomfort—Bleomycin—lymphatic system cancer	4.22e-05	0.00144	CcSEcCtD
Decitabine—Mental disorder—Vincristine—lymphatic system cancer	4.2e-05	0.00143	CcSEcCtD
Decitabine—Chills—Mitoxantrone—lymphatic system cancer	4.19e-05	0.00143	CcSEcCtD
Decitabine—Ecchymosis—Methotrexate—lymphatic system cancer	4.19e-05	0.00143	CcSEcCtD
Decitabine—Alopecia—Mitoxantrone—lymphatic system cancer	4.13e-05	0.00141	CcSEcCtD
Decitabine—Pulmonary oedema—Methotrexate—lymphatic system cancer	4.13e-05	0.00141	CcSEcCtD
Decitabine—Confusional state—Bleomycin—lymphatic system cancer	4.12e-05	0.00141	CcSEcCtD
Decitabine—Vision blurred—Carmustine—lymphatic system cancer	4.12e-05	0.0014	CcSEcCtD
Decitabine—Hypersensitivity—Fludarabine—lymphatic system cancer	4.11e-05	0.0014	CcSEcCtD
Decitabine—Anaphylactic shock—Bleomycin—lymphatic system cancer	4.09e-05	0.00139	CcSEcCtD
Decitabine—Oedema—Bleomycin—lymphatic system cancer	4.09e-05	0.00139	CcSEcCtD
Decitabine—Erythema—Mitoxantrone—lymphatic system cancer	4.07e-05	0.00139	CcSEcCtD
Decitabine—Infection—Bleomycin—lymphatic system cancer	4.06e-05	0.00138	CcSEcCtD
Decitabine—Anaemia—Carmustine—lymphatic system cancer	4.04e-05	0.00138	CcSEcCtD
Decitabine—Back pain—Vincristine—lymphatic system cancer	4.04e-05	0.00138	CcSEcCtD
Decitabine—Vomiting—Teniposide—lymphatic system cancer	4.04e-05	0.00138	CcSEcCtD
Decitabine—Sepsis—Methotrexate—lymphatic system cancer	4.02e-05	0.00137	CcSEcCtD
Decitabine—Thrombocytopenia—Bleomycin—lymphatic system cancer	4e-05	0.00136	CcSEcCtD
Decitabine—Asthenia—Fludarabine—lymphatic system cancer	4e-05	0.00136	CcSEcCtD
Decitabine—Rash—Teniposide—lymphatic system cancer	4e-05	0.00136	CcSEcCtD
Decitabine—Dermatitis—Teniposide—lymphatic system cancer	4e-05	0.00136	CcSEcCtD
Decitabine—Headache—Teniposide—lymphatic system cancer	3.98e-05	0.00136	CcSEcCtD
Decitabine—Pruritus—Fludarabine—lymphatic system cancer	3.95e-05	0.00135	CcSEcCtD
Decitabine—Lymphadenopathy—Methotrexate—lymphatic system cancer	3.94e-05	0.00134	CcSEcCtD
Decitabine—Back pain—Mitoxantrone—lymphatic system cancer	3.93e-05	0.00134	CcSEcCtD
Decitabine—Leukopenia—Carmustine—lymphatic system cancer	3.92e-05	0.00133	CcSEcCtD
Decitabine—Anorexia—Bleomycin—lymphatic system cancer	3.9e-05	0.00133	CcSEcCtD
Decitabine—Anaemia—Vincristine—lymphatic system cancer	3.86e-05	0.00132	CcSEcCtD
Decitabine—Vision blurred—Mitoxantrone—lymphatic system cancer	3.83e-05	0.00131	CcSEcCtD
Decitabine—Hypotension—Bleomycin—lymphatic system cancer	3.82e-05	0.0013	CcSEcCtD
Decitabine—Diarrhoea—Fludarabine—lymphatic system cancer	3.82e-05	0.0013	CcSEcCtD
Decitabine—Hypertension—Carmustine—lymphatic system cancer	3.78e-05	0.00129	CcSEcCtD
Decitabine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	3.77e-05	0.00129	CcSEcCtD
Decitabine—Nausea—Teniposide—lymphatic system cancer	3.77e-05	0.00128	CcSEcCtD
Decitabine—Anaemia—Mitoxantrone—lymphatic system cancer	3.76e-05	0.00128	CcSEcCtD
Decitabine—Leukopenia—Vincristine—lymphatic system cancer	3.74e-05	0.00127	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	3.73e-05	0.00127	CcSEcCtD
Decitabine—Chest pain—Carmustine—lymphatic system cancer	3.72e-05	0.00127	CcSEcCtD
Decitabine—Myalgia—Carmustine—lymphatic system cancer	3.72e-05	0.00127	CcSEcCtD
Decitabine—Anxiety—Carmustine—lymphatic system cancer	3.71e-05	0.00126	CcSEcCtD
Decitabine—Malaise—Mitoxantrone—lymphatic system cancer	3.67e-05	0.00125	CcSEcCtD
Decitabine—Dyspnoea—Bleomycin—lymphatic system cancer	3.65e-05	0.00124	CcSEcCtD
Decitabine—Leukopenia—Mitoxantrone—lymphatic system cancer	3.64e-05	0.00124	CcSEcCtD
Decitabine—Hypertension—Vincristine—lymphatic system cancer	3.61e-05	0.00123	CcSEcCtD
Decitabine—Confusional state—Carmustine—lymphatic system cancer	3.6e-05	0.00123	CcSEcCtD
Decitabine—Oedema—Carmustine—lymphatic system cancer	3.57e-05	0.00122	CcSEcCtD
Decitabine—Decreased appetite—Bleomycin—lymphatic system cancer	3.56e-05	0.00121	CcSEcCtD
Decitabine—Myalgia—Vincristine—lymphatic system cancer	3.56e-05	0.00121	CcSEcCtD
Decitabine—Cough—Mitoxantrone—lymphatic system cancer	3.55e-05	0.00121	CcSEcCtD
Decitabine—Infection—Carmustine—lymphatic system cancer	3.55e-05	0.00121	CcSEcCtD
Decitabine—Vomiting—Fludarabine—lymphatic system cancer	3.55e-05	0.00121	CcSEcCtD
Decitabine—Rash—Fludarabine—lymphatic system cancer	3.52e-05	0.0012	CcSEcCtD
Decitabine—Dermatitis—Fludarabine—lymphatic system cancer	3.51e-05	0.0012	CcSEcCtD
Decitabine—Hypertension—Mitoxantrone—lymphatic system cancer	3.51e-05	0.0012	CcSEcCtD
Decitabine—Pain—Bleomycin—lymphatic system cancer	3.5e-05	0.00119	CcSEcCtD
Decitabine—Thrombocytopenia—Carmustine—lymphatic system cancer	3.5e-05	0.00119	CcSEcCtD
Decitabine—Headache—Fludarabine—lymphatic system cancer	3.49e-05	0.00119	CcSEcCtD
Decitabine—Tachycardia—Carmustine—lymphatic system cancer	3.48e-05	0.00119	CcSEcCtD
Decitabine—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	3.48e-05	0.00118	CcSEcCtD
Decitabine—Chest pain—Mitoxantrone—lymphatic system cancer	3.46e-05	0.00118	CcSEcCtD
Decitabine—Arthralgia—Mitoxantrone—lymphatic system cancer	3.46e-05	0.00118	CcSEcCtD
Decitabine—Myalgia—Mitoxantrone—lymphatic system cancer	3.46e-05	0.00118	CcSEcCtD
Decitabine—Anxiety—Mitoxantrone—lymphatic system cancer	3.45e-05	0.00118	CcSEcCtD
Decitabine—Lethargy—Methotrexate—lymphatic system cancer	3.43e-05	0.00117	CcSEcCtD
Decitabine—Discomfort—Mitoxantrone—lymphatic system cancer	3.42e-05	0.00117	CcSEcCtD
Decitabine—Oedema—Vincristine—lymphatic system cancer	3.41e-05	0.00116	CcSEcCtD
Decitabine—Anaphylactic shock—Vincristine—lymphatic system cancer	3.41e-05	0.00116	CcSEcCtD
Decitabine—Anorexia—Carmustine—lymphatic system cancer	3.4e-05	0.00116	CcSEcCtD
Decitabine—Infection—Vincristine—lymphatic system cancer	3.39e-05	0.00115	CcSEcCtD
Decitabine—Feeling abnormal—Bleomycin—lymphatic system cancer	3.37e-05	0.00115	CcSEcCtD
Decitabine—Confusional state—Mitoxantrone—lymphatic system cancer	3.35e-05	0.00114	CcSEcCtD
Decitabine—Nervous system disorder—Vincristine—lymphatic system cancer	3.34e-05	0.00114	CcSEcCtD
Decitabine—Thrombocytopenia—Vincristine—lymphatic system cancer	3.34e-05	0.00114	CcSEcCtD
Decitabine—Hypotension—Carmustine—lymphatic system cancer	3.34e-05	0.00114	CcSEcCtD
Decitabine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	3.32e-05	0.00113	CcSEcCtD
Decitabine—Oedema—Mitoxantrone—lymphatic system cancer	3.32e-05	0.00113	CcSEcCtD
Decitabine—Nausea—Fludarabine—lymphatic system cancer	3.31e-05	0.00113	CcSEcCtD
Decitabine—Infection—Mitoxantrone—lymphatic system cancer	3.3e-05	0.00112	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	3.25e-05	0.00111	CcSEcCtD
Decitabine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	3.25e-05	0.00111	CcSEcCtD
Decitabine—Urticaria—Bleomycin—lymphatic system cancer	3.25e-05	0.00111	CcSEcCtD
Decitabine—Anorexia—Vincristine—lymphatic system cancer	3.25e-05	0.00111	CcSEcCtD
Decitabine—Tachycardia—Mitoxantrone—lymphatic system cancer	3.24e-05	0.0011	CcSEcCtD
Decitabine—Body temperature increased—Bleomycin—lymphatic system cancer	3.23e-05	0.0011	CcSEcCtD
Decitabine—Insomnia—Carmustine—lymphatic system cancer	3.23e-05	0.0011	CcSEcCtD
Decitabine—Skin disorder—Mitoxantrone—lymphatic system cancer	3.22e-05	0.0011	CcSEcCtD
Decitabine—Hypotension—Vincristine—lymphatic system cancer	3.18e-05	0.00109	CcSEcCtD
Decitabine—Dyspnoea—Carmustine—lymphatic system cancer	3.18e-05	0.00108	CcSEcCtD
Decitabine—Anorexia—Mitoxantrone—lymphatic system cancer	3.16e-05	0.00108	CcSEcCtD
Decitabine—Liver function test abnormal—Methotrexate—lymphatic system cancer	3.11e-05	0.00106	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	3.1e-05	0.00106	CcSEcCtD
Decitabine—Decreased appetite—Carmustine—lymphatic system cancer	3.1e-05	0.00106	CcSEcCtD
Decitabine—Hypotension—Mitoxantrone—lymphatic system cancer	3.1e-05	0.00106	CcSEcCtD
Decitabine—Insomnia—Vincristine—lymphatic system cancer	3.08e-05	0.00105	CcSEcCtD
Decitabine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	3.08e-05	0.00105	CcSEcCtD
Decitabine—Pain—Carmustine—lymphatic system cancer	3.05e-05	0.00104	CcSEcCtD
Decitabine—Constipation—Carmustine—lymphatic system cancer	3.05e-05	0.00104	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	3.02e-05	0.00103	CcSEcCtD
Decitabine—Hypersensitivity—Bleomycin—lymphatic system cancer	3.01e-05	0.00103	CcSEcCtD
Decitabine—Decreased appetite—Vincristine—lymphatic system cancer	2.96e-05	0.00101	CcSEcCtD
Decitabine—Dyspnoea—Mitoxantrone—lymphatic system cancer	2.96e-05	0.00101	CcSEcCtD
Decitabine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	2.94e-05	0.001	CcSEcCtD
Decitabine—Feeling abnormal—Carmustine—lymphatic system cancer	2.94e-05	0.001	CcSEcCtD
Decitabine—Fatigue—Vincristine—lymphatic system cancer	2.94e-05	0.001	CcSEcCtD
Decitabine—Asthenia—Bleomycin—lymphatic system cancer	2.93e-05	0.001	CcSEcCtD
Decitabine—Dyspepsia—Mitoxantrone—lymphatic system cancer	2.92e-05	0.000996	CcSEcCtD
Decitabine—Gastrointestinal pain—Carmustine—lymphatic system cancer	2.92e-05	0.000995	CcSEcCtD
Decitabine—Constipation—Vincristine—lymphatic system cancer	2.91e-05	0.000993	CcSEcCtD
Decitabine—Pain—Vincristine—lymphatic system cancer	2.91e-05	0.000993	CcSEcCtD
Decitabine—Pruritus—Bleomycin—lymphatic system cancer	2.89e-05	0.000986	CcSEcCtD
Decitabine—Decreased appetite—Mitoxantrone—lymphatic system cancer	2.89e-05	0.000983	CcSEcCtD
Decitabine—Fatigue—Mitoxantrone—lymphatic system cancer	2.86e-05	0.000975	CcSEcCtD
Decitabine—Pain—Mitoxantrone—lymphatic system cancer	2.84e-05	0.000967	CcSEcCtD
Decitabine—Constipation—Mitoxantrone—lymphatic system cancer	2.84e-05	0.000967	CcSEcCtD
Decitabine—Abdominal pain—Carmustine—lymphatic system cancer	2.82e-05	0.000962	CcSEcCtD
Decitabine—Body temperature increased—Carmustine—lymphatic system cancer	2.82e-05	0.000962	CcSEcCtD
Decitabine—Gastrointestinal pain—Vincristine—lymphatic system cancer	2.79e-05	0.00095	CcSEcCtD
Decitabine—Pancytopenia—Methotrexate—lymphatic system cancer	2.76e-05	0.000941	CcSEcCtD
Decitabine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	2.74e-05	0.000932	CcSEcCtD
Decitabine—Neutropenia—Methotrexate—lymphatic system cancer	2.72e-05	0.000927	CcSEcCtD
Decitabine—Dysuria—Methotrexate—lymphatic system cancer	2.72e-05	0.000927	CcSEcCtD
Decitabine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	2.71e-05	0.000925	CcSEcCtD
Decitabine—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	2.7e-05	0.000921	CcSEcCtD
Decitabine—Abdominal pain—Vincristine—lymphatic system cancer	2.69e-05	0.000918	CcSEcCtD
Decitabine—Body temperature increased—Vincristine—lymphatic system cancer	2.69e-05	0.000918	CcSEcCtD
Decitabine—Urticaria—Mitoxantrone—lymphatic system cancer	2.64e-05	0.000899	CcSEcCtD
Decitabine—Hypersensitivity—Carmustine—lymphatic system cancer	2.63e-05	0.000896	CcSEcCtD
Decitabine—Abdominal pain—Mitoxantrone—lymphatic system cancer	2.62e-05	0.000894	CcSEcCtD
Decitabine—Body temperature increased—Mitoxantrone—lymphatic system cancer	2.62e-05	0.000894	CcSEcCtD
Decitabine—Pneumonia—Methotrexate—lymphatic system cancer	2.61e-05	0.000889	CcSEcCtD
Decitabine—Vomiting—Bleomycin—lymphatic system cancer	2.6e-05	0.000886	CcSEcCtD
Decitabine—Infestation NOS—Methotrexate—lymphatic system cancer	2.59e-05	0.000884	CcSEcCtD
Decitabine—Infestation—Methotrexate—lymphatic system cancer	2.59e-05	0.000884	CcSEcCtD
Decitabine—Depression—Methotrexate—lymphatic system cancer	2.59e-05	0.000881	CcSEcCtD
Decitabine—Rash—Bleomycin—lymphatic system cancer	2.58e-05	0.000879	CcSEcCtD
Decitabine—Dermatitis—Bleomycin—lymphatic system cancer	2.58e-05	0.000878	CcSEcCtD
Decitabine—Asthenia—Carmustine—lymphatic system cancer	2.56e-05	0.000873	CcSEcCtD
Decitabine—Renal failure—Methotrexate—lymphatic system cancer	2.55e-05	0.000869	CcSEcCtD
Decitabine—Stomatitis—Methotrexate—lymphatic system cancer	2.53e-05	0.000861	CcSEcCtD
Decitabine—Hypersensitivity—Vincristine—lymphatic system cancer	2.51e-05	0.000856	CcSEcCtD
Decitabine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	2.45e-05	0.000836	CcSEcCtD
Decitabine—Epistaxis—Methotrexate—lymphatic system cancer	2.45e-05	0.000833	CcSEcCtD
Decitabine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	2.45e-05	0.000833	CcSEcCtD
Decitabine—Asthenia—Vincristine—lymphatic system cancer	2.45e-05	0.000833	CcSEcCtD
Decitabine—Diarrhoea—Carmustine—lymphatic system cancer	2.44e-05	0.000832	CcSEcCtD
Decitabine—Nausea—Bleomycin—lymphatic system cancer	2.43e-05	0.000828	CcSEcCtD
Decitabine—Asthenia—Mitoxantrone—lymphatic system cancer	2.38e-05	0.000812	CcSEcCtD
Decitabine—Dizziness—Carmustine—lymphatic system cancer	2.36e-05	0.000805	CcSEcCtD
Decitabine—Haemoglobin—Methotrexate—lymphatic system cancer	2.34e-05	0.000797	CcSEcCtD
Decitabine—Diarrhoea—Vincristine—lymphatic system cancer	2.33e-05	0.000795	CcSEcCtD
Decitabine—Haemorrhage—Methotrexate—lymphatic system cancer	2.33e-05	0.000793	CcSEcCtD
Decitabine—Pharyngitis—Methotrexate—lymphatic system cancer	2.31e-05	0.000787	CcSEcCtD
Decitabine—Urinary tract disorder—Methotrexate—lymphatic system cancer	2.3e-05	0.000783	CcSEcCtD
Decitabine—Urethral disorder—Methotrexate—lymphatic system cancer	2.28e-05	0.000778	CcSEcCtD
Decitabine—Diarrhoea—Mitoxantrone—lymphatic system cancer	2.27e-05	0.000774	CcSEcCtD
Decitabine—Vomiting—Carmustine—lymphatic system cancer	2.27e-05	0.000774	CcSEcCtD
Decitabine—Dizziness—Vincristine—lymphatic system cancer	2.25e-05	0.000768	CcSEcCtD
Decitabine—Rash—Carmustine—lymphatic system cancer	2.25e-05	0.000767	CcSEcCtD
Decitabine—Dermatitis—Carmustine—lymphatic system cancer	2.25e-05	0.000766	CcSEcCtD
Decitabine—Headache—Carmustine—lymphatic system cancer	2.24e-05	0.000762	CcSEcCtD
Decitabine—Eye disorder—Methotrexate—lymphatic system cancer	2.18e-05	0.000741	CcSEcCtD
Decitabine—Vomiting—Vincristine—lymphatic system cancer	2.17e-05	0.000738	CcSEcCtD
Decitabine—Cardiac disorder—Methotrexate—lymphatic system cancer	2.16e-05	0.000736	CcSEcCtD
Decitabine—Rash—Vincristine—lymphatic system cancer	2.15e-05	0.000732	CcSEcCtD
Decitabine—Dermatitis—Vincristine—lymphatic system cancer	2.15e-05	0.000732	CcSEcCtD
Decitabine—Headache—Vincristine—lymphatic system cancer	2.14e-05	0.000728	CcSEcCtD
Decitabine—Nausea—Carmustine—lymphatic system cancer	2.12e-05	0.000723	CcSEcCtD
Decitabine—Angiopathy—Methotrexate—lymphatic system cancer	2.11e-05	0.00072	CcSEcCtD
Decitabine—Vomiting—Mitoxantrone—lymphatic system cancer	2.11e-05	0.000719	CcSEcCtD
Decitabine—Immune system disorder—Methotrexate—lymphatic system cancer	2.1e-05	0.000716	CcSEcCtD
Decitabine—Mediastinal disorder—Methotrexate—lymphatic system cancer	2.1e-05	0.000715	CcSEcCtD
Decitabine—Rash—Mitoxantrone—lymphatic system cancer	2.09e-05	0.000713	CcSEcCtD
Decitabine—Dermatitis—Mitoxantrone—lymphatic system cancer	2.09e-05	0.000713	CcSEcCtD
Decitabine—Chills—Methotrexate—lymphatic system cancer	2.09e-05	0.000712	CcSEcCtD
Decitabine—Headache—Mitoxantrone—lymphatic system cancer	2.08e-05	0.000709	CcSEcCtD
Decitabine—Alopecia—Methotrexate—lymphatic system cancer	2.06e-05	0.000701	CcSEcCtD
Decitabine—Mental disorder—Methotrexate—lymphatic system cancer	2.04e-05	0.000695	CcSEcCtD
Decitabine—Malnutrition—Methotrexate—lymphatic system cancer	2.03e-05	0.000691	CcSEcCtD
Decitabine—Erythema—Methotrexate—lymphatic system cancer	2.03e-05	0.000691	CcSEcCtD
Decitabine—Nausea—Vincristine—lymphatic system cancer	2.02e-05	0.00069	CcSEcCtD
Decitabine—Nausea—Mitoxantrone—lymphatic system cancer	1.97e-05	0.000672	CcSEcCtD
Decitabine—Back pain—Methotrexate—lymphatic system cancer	1.96e-05	0.000668	CcSEcCtD
Decitabine—Vision blurred—Methotrexate—lymphatic system cancer	1.91e-05	0.000651	CcSEcCtD
Decitabine—Ill-defined disorder—Methotrexate—lymphatic system cancer	1.88e-05	0.000641	CcSEcCtD
Decitabine—Anaemia—Methotrexate—lymphatic system cancer	1.87e-05	0.000638	CcSEcCtD
Decitabine—Malaise—Methotrexate—lymphatic system cancer	1.83e-05	0.000623	CcSEcCtD
Decitabine—Leukopenia—Methotrexate—lymphatic system cancer	1.81e-05	0.000618	CcSEcCtD
Decitabine—Cough—Methotrexate—lymphatic system cancer	1.77e-05	0.000603	CcSEcCtD
Decitabine—Arthralgia—Methotrexate—lymphatic system cancer	1.73e-05	0.000588	CcSEcCtD
Decitabine—Myalgia—Methotrexate—lymphatic system cancer	1.73e-05	0.000588	CcSEcCtD
Decitabine—Chest pain—Methotrexate—lymphatic system cancer	1.73e-05	0.000588	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	1.71e-05	0.000584	CcSEcCtD
Decitabine—Discomfort—Methotrexate—lymphatic system cancer	1.7e-05	0.000581	CcSEcCtD
Decitabine—Confusional state—Methotrexate—lymphatic system cancer	1.67e-05	0.000568	CcSEcCtD
Decitabine—Anaphylactic shock—Methotrexate—lymphatic system cancer	1.65e-05	0.000564	CcSEcCtD
Decitabine—Infection—Methotrexate—lymphatic system cancer	1.64e-05	0.00056	CcSEcCtD
Decitabine—Nervous system disorder—Methotrexate—lymphatic system cancer	1.62e-05	0.000553	CcSEcCtD
Decitabine—Thrombocytopenia—Methotrexate—lymphatic system cancer	1.62e-05	0.000552	CcSEcCtD
Decitabine—Skin disorder—Methotrexate—lymphatic system cancer	1.61e-05	0.000547	CcSEcCtD
Decitabine—Anorexia—Methotrexate—lymphatic system cancer	1.58e-05	0.000537	CcSEcCtD
Decitabine—Hypotension—Methotrexate—lymphatic system cancer	1.55e-05	0.000527	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	1.51e-05	0.000513	CcSEcCtD
Decitabine—Insomnia—Methotrexate—lymphatic system cancer	1.5e-05	0.00051	CcSEcCtD
Decitabine—Dyspnoea—Methotrexate—lymphatic system cancer	1.47e-05	0.000502	CcSEcCtD
Decitabine—Dyspepsia—Methotrexate—lymphatic system cancer	1.46e-05	0.000496	CcSEcCtD
Decitabine—Decreased appetite—Methotrexate—lymphatic system cancer	1.44e-05	0.00049	CcSEcCtD
Decitabine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	1.43e-05	0.000487	CcSEcCtD
Decitabine—Fatigue—Methotrexate—lymphatic system cancer	1.43e-05	0.000486	CcSEcCtD
Decitabine—Pain—Methotrexate—lymphatic system cancer	1.41e-05	0.000482	CcSEcCtD
Decitabine—Feeling abnormal—Methotrexate—lymphatic system cancer	1.36e-05	0.000464	CcSEcCtD
Decitabine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	1.35e-05	0.000461	CcSEcCtD
Decitabine—Urticaria—Methotrexate—lymphatic system cancer	1.31e-05	0.000448	CcSEcCtD
Decitabine—Body temperature increased—Methotrexate—lymphatic system cancer	1.31e-05	0.000446	CcSEcCtD
Decitabine—Abdominal pain—Methotrexate—lymphatic system cancer	1.31e-05	0.000446	CcSEcCtD
Decitabine—Hypersensitivity—Methotrexate—lymphatic system cancer	1.22e-05	0.000415	CcSEcCtD
Decitabine—Asthenia—Methotrexate—lymphatic system cancer	1.19e-05	0.000404	CcSEcCtD
Decitabine—Pruritus—Methotrexate—lymphatic system cancer	1.17e-05	0.000399	CcSEcCtD
Decitabine—Diarrhoea—Methotrexate—lymphatic system cancer	1.13e-05	0.000386	CcSEcCtD
Decitabine—Dizziness—Methotrexate—lymphatic system cancer	1.09e-05	0.000373	CcSEcCtD
Decitabine—Vomiting—Methotrexate—lymphatic system cancer	1.05e-05	0.000358	CcSEcCtD
Decitabine—Rash—Methotrexate—lymphatic system cancer	1.04e-05	0.000355	CcSEcCtD
Decitabine—Dermatitis—Methotrexate—lymphatic system cancer	1.04e-05	0.000355	CcSEcCtD
Decitabine—Headache—Methotrexate—lymphatic system cancer	1.04e-05	0.000353	CcSEcCtD
Decitabine—Nausea—Methotrexate—lymphatic system cancer	9.82e-06	0.000335	CcSEcCtD
